Labo Plus SRL
3.0 FTEThe score of Labo Plus shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2024
Change 2021 → 2024: Equity 0 % Total assets +10 % Headcount (avg FTE) 0 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Labo Plus's annual accounts
Filed annual accounts
- Year ended 31 Dec 2024filed on 16 Sep 2025
- Year ended 31 Dec 2023filed on 23 Sep 2024
- Year ended 31 Dec 2022filed on 29 Sep 2023
- Year ended 31 Dec 2021filed on 21 Sep 2022
- Year ended 31 Dec 2020filed on 08 Nov 2021
Labo Plus's financial analysis
- Solvency27.2%sector median: 36.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Labo Plus
Labo Plus's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0822.666.896
- VAT number
- BE0822666896
- Peppol
- Registered · 0208:0822666896 · as of 06 Nov 2026
- Legal form
- SRL
- Incorporated
- 27 Jan 2010
- Registered office
- 1200 Woluwe-Saint-Lambert
- Size
- Micro · 3.0 FTE
- Latest accounts
- 2024 · filed on 16 Sep 2025
- Activity
- Manufacture of medical and dental instruments and supplies (NACE 32500)
Labo Plus (SRL) has been based in Woluwe-Saint-Lambert since 2010, active in: manufacture of medical and dental instruments and supplies. For 2024, it reports a net loss of 5,646 € and equity of 136,537 €; its revenue is not published. With 3.0 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 27.2%, below the median of its sector (36.2%).
Companies similar to Labo Plus
Companies in the same business, of comparable size and area, outside its group.
- PerioDovas Manufacture of medical and dental instruments and supplies Leuven · balance sheet 294,279 €
- Orthodentix Manufacture of medical and dental instruments and supplies Kortrijk · balance sheet 496,621 €
- Ortho-Dynamics Manufacture of medical and dental instruments and supplies Waregem · balance sheet 545,935 €
- Brace2U Manufacture of medical and dental instruments and supplies Boutersem · balance sheet 664,471 €
- LAB - G Manufacture of medical and dental instruments and supplies Nivelles · balance sheet 303,005 €
- MD Management Manufacture of medical and dental instruments and supplies Brussels · balance sheet 215,379 €
- Reskin Medical Manufacture of medical and dental instruments and supplies Tessenderlo-Ham · balance sheet 712,431 €
- Global Smile Manufacture of medical and dental instruments and supplies Lokeren · balance sheet 264,204 €
Frequently asked questions about Labo Plus
What is the revenue of Labo Plus?
Labo Plus files its accounts in a format where revenue is optional: it is not published for 2024.
What is the VAT number of Labo Plus?
In Belgium, the VAT number is the company number prefixed with BE: BE0822666896 for Labo Plus, if the company is VAT-registered. Its company number (CBE) is 0822.666.896.
Where is the registered office of Labo Plus?
According to the CBE register, the registered office of Labo Plus is in 1200 Woluwe-Saint-Lambert.
What is the equity of Labo Plus?
At the close of the 2024 financial year, the equity of Labo Plus amounts to 136,537 €, a solvency of 27.2% of total assets.
How many people work at Labo Plus?
3.0 full-time equivalents on average according to the 2024 social balance sheet.
Who manages Labo Plus?
The register lists 3 active mandates at Labo Plus. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Labo Plus
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →